RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Immuno-Biological Laboratories Co - Stock

Immuno-Biological Laboratories Co Debt 2024

Immuno-Biological Laboratories Co Debt

-498.15 JPY

Ticker

4570.T

ISIN

JP3921300004

In 2024, Immuno-Biological Laboratories Co's total debt was -498.15 JPY, a 81.57% change from the -274.35 JPY total debt recorded in the previous year.

Immuno-Biological Laboratories Co Aktienanalyse

What does Immuno-Biological Laboratories Co do?

Immuno-Biological Laboratories Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Immuno-Biological Laboratories Co's Debt Structure

Immuno-Biological Laboratories Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Immuno-Biological Laboratories Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Immuno-Biological Laboratories Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Immuno-Biological Laboratories Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Immuno-Biological Laboratories Co stock

What is the debt of Immuno-Biological Laboratories Co this year?

Immuno-Biological Laboratories Co has a debt level of -498.15 JPY this year.

What was the debt of Immuno-Biological Laboratories Co compared to the previous year?

The debt of Immuno-Biological Laboratories Co has increased by 81.57% compared to the previous year increased.

What are the consequences of high debt for investors in Immuno-Biological Laboratories Co?

High debt can pose a risk for investors of Immuno-Biological Laboratories Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Immuno-Biological Laboratories Co?

Low debt means that Immuno-Biological Laboratories Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Immuno-Biological Laboratories Co affect the company?

An increase in debt of Immuno-Biological Laboratories Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Immuno-Biological Laboratories Co affect the company?

A reduction in debt of Immuno-Biological Laboratories Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Immuno-Biological Laboratories Co?

Some factors that can influence the debt of Immuno-Biological Laboratories Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Immuno-Biological Laboratories Co so important for investors?

The debts of Immuno-Biological Laboratories Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Immuno-Biological Laboratories Co take to change the debt?

To change the debt, Immuno-Biological Laboratories Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Immuno-Biological Laboratories Co pay?

Over the past 12 months, Immuno-Biological Laboratories Co paid a dividend of 5 JPY . This corresponds to a dividend yield of about 0.96 %. For the coming 12 months, Immuno-Biological Laboratories Co is expected to pay a dividend of 0 JPY.

What is the dividend yield of Immuno-Biological Laboratories Co?

The current dividend yield of Immuno-Biological Laboratories Co is 0.96 %.

When does Immuno-Biological Laboratories Co pay dividends?

Immuno-Biological Laboratories Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Immuno-Biological Laboratories Co?

Immuno-Biological Laboratories Co paid dividends every year for the past 0 years.

What is the dividend of Immuno-Biological Laboratories Co?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Immuno-Biological Laboratories Co located?

Immuno-Biological Laboratories Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Immuno-Biological Laboratories Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Immuno-Biological Laboratories Co from 6/28/2013 amounting to 50 JPY, you needed to have the stock in your portfolio before the ex-date on 3/27/2013.

When did Immuno-Biological Laboratories Co pay the last dividend?

The last dividend was paid out on 6/28/2013.

What was the dividend of Immuno-Biological Laboratories Co in the year 2023?

In the year 2023, Immuno-Biological Laboratories Co distributed 0 JPY as dividends.

In which currency does Immuno-Biological Laboratories Co pay out the dividend?

The dividends of Immuno-Biological Laboratories Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Immuno-Biological Laboratories Co

Our stock analysis for Immuno-Biological Laboratories Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Immuno-Biological Laboratories Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.